
COVIDã¯ã¯ãã³ã¯ãäŒæãããã®ãïŒæçµäžé ã®ç ç©¶ããããªãç ç©¶ã®å¿ èŠæ§ãæµ®ã圫ãã«ãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
COVID-19ã¯ã¯ãã³ãæ¥çš®ããŠããããCOVID-19ææçã«ããã£ãŠããªã女æ§ããCOVID-19ã¯ã¯ãã³ãæ¥çš®ãã女æ§ãšåãæçµç°åžžãå€ãã¿ãããããšããæ»èªãåããæ°ããç ç©¶ã§å ±åããããChildren's Health Defenseç§åŠããŒã ã®ã¡ã³ããŒã¯ããã®ç ç©¶ã®ç ç©¶ãšå·çã«ååããã
æ»èªãåããæ°ããç ç©¶ã«ãããšãCOVID-19ã¯ã¯ãã³ãæ¥çš®ããŠããããCOVID-19ã«ææããããšã®ãªã女æ§ã¯ãCOVID-19ã¯ã¯ãã³ãæ¥çš®ãã女æ§ãšåãæçµç°åžžã®å€ããå ±åããã
ç ç©¶èè ãã¯12æ7æ¥ããInternational Journal of Vaccine Theory, Practice, and Researchãèªã«ç ç©¶çµæãçºè¡šããã
ç ç©¶ã«ãããšã85.5ïŒ ã®å¥³æ§ãã¯ã¯ãã³æ¥çš®è ãã6ãã£ãŒã以å ã«ãããšå ±åããŠããããã®ãã¡71.7ïŒ ã«1é±é以å ã«ã50.1ïŒ ã«3æ¥ä»¥å ã«æçµäžé ã®çç¶ãã¿ãããã
å è¡ç ç©¶ã§ã¯ãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã«æçµç°åžžãçµéšãã女æ§ãããããšã瀺åãããŠããããæ¬ç ç©¶ã¯ãã¯ã¯ãã³æªæ¥çš®ã®å¥³æ§ãCOVID-19ã¯ã¯ãã³ã®éæ¥æŽé²åŸã«æçµç°åžžãçµéšããããšã瀺åããæåã®ç ç©¶ã®ã²ãšã€ã§ããããšèè ãã¯è¿°ã¹ãŠããã
ãæã ã®ç¥ãéããæ¬ç ç©¶ã¯ãæ¥åžžç掻ã«ãããã¯ã¯ãã³æ¥çš®è ãšã®è¿æ¥æ§ãšæçµäžé ãšã®é¢é£ãããã³ã¯ã¯ãã³æ¥çš®è ãšè¿æ¥ããåŸã®æçµç°åžžã®çºçŸææã«ã€ããŠå ±åããåããŠã®ããç ç©¶ã§ãã ããšç ç©¶å ±åæžã«èè ãã¯èšããŠããã
ç ç©¶èè ãã¯ãCOVID-19ã®æææŽããªããCOVID-19ã®çç¶ããªãCOVID-19ã¯ã¯ãã³æªæ¥çš®ã®å¥³æ§3,390人ãã2021幎ã«åéãã調æ»ããŒã¿ãåæããã
çµ±èšè§£æã«ãããèè ãã¯ãCOVID-19ã®ã¯ã¯ãã³ãæ¥çš®ããŠãã人ãšã®è·é¢ãè¿ããã©ãããã女æ§ã®æçµäžé ã®ãªã¹ã¯ãšé¢é£ããŠãããã©ããã調ã¹ãã
ãã®çµæãCOVID-19æææŽã®ãªãã¯ã¯ãã³æªæ¥çš®ã®å¥³æ§ã§ãCOVID-19ã¯ã¯ãã³ãæ¥çš®ããŠããå®¶åºå€ã®äººã ãšæ¥åžžçã«å¯æ¥ãªæ¥è§ŠïŒ6ãã£ãŒã以å ïŒãæã€å¥³æ§ã¯ãCOVID-19æææŽã®ãªãã¯ã¯ãã³æªæ¥çš®ã®å¥³æ§ã§ã¯ã¯ãã³æ¥çš®è ãšã®å¯æ¥ãªæ¥è§Šãã»ãšãã©æããªã女æ§ãšæ¯èŒããŠãæçµäžé ã®ãªã¹ã¯ãçµ±èšåŠçã«ææã«é«ãããšã倿ããã
ãŸããã¯ã¯ãã³æ¥çš®ãåããéå®¶åºã®äººãšã®6ãã£ãŒã以å ã®æ¥è§Šã ãæ¯æ¥ ããã ãæã ãã«æžå°ãããšãæçµäžé ã®ãªã¹ã¯ãé«ããªãããšãããã£ãã
ããããã¯ã¯ãã³æªæ¥çš®è ãšåãäžåž¯ã®ã¯ã¯ãã³æ¥çš®è ãšã®æ¯æ¥ã®å¯æ¥ãªæ¥è§Šã¯ãã¯ã¯ãã³æªæ¥çš®å¥³æ§ã®æçµäžé ãªã¹ã¯ãå¢å ãããªãããšãããã£ãã
COVID-19æææŽã®ãªãã¯ã¯ãã³æªæ¥çš®ã®å¥³æ§ã§ãã¯ã¯ãã³æ¥çš®ãåããå®¶åºã®äžå¡ãææçžæãšæ¥åžžçã«å¯æ¥ãªæ¥è§Šããã£ãŠããã¯ã¯ãã³æ¥çš®ãåãã人ãšã»ãšãã©å¯æ¥ãªæ¥è§ŠããªãCOVID-19æææŽã®ãªãã¯ã¯ãã³æªæ¥çš®ã®å¥³æ§ãšæ¯èŒããŠãæçµäžé ã®ãªã¹ã¯ã¯é«ããªãã£ãã
å ±åæžã«ãããš
ãç ç©¶ããŒã ã¯ãæ¥åžžçã«ã¯ã¯ãã³æ¥çš®è ãšã®è·é¢ãè¿ããã°è¿ãã»ã©ãç°åžžçç¶ã®çžå¯Ÿçãªã¹ã¯ãé«ããªããšãã仮説ãç«ãŠããããã¯ããããã®æèŠã§ã¯ãªãã£ããããŒãããŒïŒè¢«æ¥çš®è ãšåå± ã察ããã£ãã«ïŒæã ïŒæ¯æ¥6ãã£ãŒãïŒçŽ1.5mïŒåå€ãã®è¿æ¥ãã€ã¢ãã®è§£æã§ã¯ã被æ¥çš®ããŒãããŒïŒåå± è ãšæ¥åžžçã«æãè¿ãè·é¢ã«ããããšããéãæçµååºã«å¯ŸããŠäºæãã¬ææãªäºé²å¹æã瀺ãããšãæããã«ãªã£ãã
ãããããåºè¡å€éïŒ34ïŒ ïŒãççæ©æçºçïŒ28ïŒ ïŒãåºè¡å»¶é·ïŒ26ïŒ ïŒãªã©ãããã€ãã®çç¶ã§ææãã€æãé«ãçžå¯Ÿãªã¹ã¯ã¯ãæ¯æ¥ã6ãã£ãŒã以å ã§è¢«æ¥çš®è ã«æŽé²ãããããå®¶åºå€ã§æŽé²ãããè ã§ãã£ãã
ããã®çµæã説æããäžã€ã®å¯èœæ§ã¯ãããå€ãã®ã¯ã¯ãã³æ¥çš®ãåããå ¬è¡éå£ã«æ¯æ¥æŽé²ãããããšã§ãç°å¢äžã«äŒæããã¯ã¯ãã³æåã®æ¿åºŠãšæŽé²æéãå¢å ããå¯èœæ§ããããšããããšã§ãããã
Children's Health DefenseïŒCHDïŒã®ããŒãã»ãµã€ãšã³ãã£ãã£ãã¯ã»ãªãã£ãµãŒã§ãããã©ã€ã¢ã³ã»ããã«ãŒæ°ã¯ãä»åã®ç ç©¶çµæã¯ãCOVID-19ã¯ã¯ãã³ã®æåºãèµ·ãã£ãŠããå¯èœæ§ã瀺åãã蚌æ ãšãªãããšããªããããæåºãèµ·ãã£ãŠããããšãã蚌æãããã®ã§ã¯ãªãããšDefenderçŽã«èªã£ãã
COVID-19ã¯ã¯ãã³ã®æåºãšã¯ãç ç©¶ã«ããã°ãCOVID-19ã¯ã¯ãã³ã®æåã補åã鿥çã«äŒæããããšãã§ããã
ãã®ç ç©¶ã®å ±èè ã§ããããã«ãŒã¯ããä»ãå ããïŒ
ããã®éèŠãªç ç©¶ã¯ãCOVID-19ã®æ¹å€mRNAãžã£ããåããå®¶åºå€ã®åäººã«æŽé²ããã女æ§ããå®¶åºå€ã®COVID-19ã¯ã¯ãã³æ¥çš®è ãšè¿æ¥ããŠããªãã£ã女æ§ããããææã«é«ãã¬ãã«ã®æçµåé¡ãå®éã«çµéšããããšã確èªãããã®ã§ãããã
Front Line COVID-19 Critical Care Allianceã®åèªäŒé·å Œæé«å»ç責任è ã§ããPierre Koryå»åž«ã¯ãSubstackã«ããã®ç 究㯠ãã¯ã¯ãã³æ¥çš®è ãšã®å¯æ¥ãªæŽé²ã«ææãªæ£è ã®ãµãã»ããã«ãããŠãæåºãèµ·ãã£ãŠãããæçµã®ç æ°ãåŒãèµ·ãããŠãããšããéåžžã«èª¬åŸåã®ããã±ãŒã¹ãäœãåºããŠãã ããšæžããŠããã
äŒæã«é¢ãããããªãç ç©¶ãå¿ èŠ
ç ç©¶èè ãã¯ãç±³åœé£åå»è¬åå±ïŒFDAïŒã2015幎ã«ããŠã€ã«ã¹ã现èãçšããéºäŒåæ²»çã«ã€ããŠãæåºè©Šéšã宿œããããã®ã¬ã€ãã³ã¹ãçºè¡šããããšãææããã
ããããCOVID-19 mRNAã¯ã¯ãã³ã®çºå£²åã«ã¯ããã®ãããªç ç©¶ã¯è¡ãããŠããªãã£ãã
ãããã«ããŒè²¡å£ã®ç«åŠè ã§ãããã³ã©ã¹ã»ãã¥ã«ã·ã£ãŒã¯ããã®ç ç©¶ã«ã€ããŠSubstackã«æçš¿ããã
ããã®ã»ãã«ãå€ãã®é倧ãªçåããããé£éŠåœå±ã«æ©æ¥ãªåçãæ±ããŠããããšãã«ã·ã£ãŒã¯èšãã
ç ç©¶èè ãã¯ããã®ç ç©¶çµæã«ã€ããŠãã2015幎ã®FDAã¬ã€ãã³ã¹ã«è©³è¿°ãããŠããããã«ãçŸåšããã³å°æ¥ã®éºäŒåæ²»ç補åã«å¯Ÿããæåºè©Šéšã®å¿ èŠæ§ãæ¯æãããã®ã§ãã ããšè¿°ã¹ãŠããã
ãéå»4幎éã女æ§ãã¡ã¯COVID-19泚å°ã®çµéšã«é¢ããŠãã¡ãã£ã¢ãå»çã·ã¹ãã ãæ¿åºæ©é¢ããçµ¶ããã¬ã¹ç¯ã济ã³ããããæ€é²ãããæ²é»ãããããŠããŸãã "ãšCHDã®ç§åŠã»ç ç©¶ã¢ããªã¹ãïŒç®¡çè ã§ãããã¶ãŒã»ã¬ã€ã¯è¿°ã¹ãããä»ããã圌女ãã¡ã«çå£ã«åãåããç§ãã¡ã®æ¯èŠªãå§åйãåšãã¡ã«äœãèµ·ãã£ãŠããã®ããç¥ããšãã§ããã
ç ç©¶èè ãã¯ãCOVID-19ã¯ã¯ãã³ã®æåãã©ã®ããã«ææããããè«ããç ç©¶ãåŒçšããããCOVID-19ã¯ã¯ãã³æ¥çš®åŸã«ãåŒæ°ãšã¢ããŸã«çµç±ãå«ããã¯ã¯ãã³æåãæäœãäŒæããå¯èœæ§ããããšãã蚌æ ãèç©ãããŠããã
ããããCOVID-19ã¯ã¯ãã³ã®æåãã¯ã¯ãã³æªæ¥çš®ã®äººã«ææããå ŽåããŸããã®æã«äœãèµ·ããããçè§£ããããšã«çŠç¹ãåœãŠãå°éå®¶ã«ããç ç©¶ã¯ã»ãšãã©ãªããããã®å ±åã¯ããã®åéã§ã®è³éãšç ç©¶ãå¢ããå¿ èŠæ§ã瀺åããŠããã
ãã®ç ç©¶ã®å ±åçé èè ã§ããã¹ãŒã»ããŒã¿ãŒãºå士ã¯ãThe Defenderèªã«æ¬¡ã®ããã«èªã£ãŠããã"ç§ã®èŠè§£ã§ã¯ããã®ç ç©¶ã®æãéèŠãªææã¯ãã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãã®äººæš©ãšããŠãããããéºäŒåæ²»çã®çäœå ååžãšæåºå¹æããã¹ãããããšã決å®çã«å¿ èŠã§ãããšããããšã§ããã
ãã§ã€ã¹ããã¯ãæçµäžé ã«é¢ãã女æ§ã®æçš¿ãåé€ããåŸã«éå§ããã調æ»
ç ç©¶å ±åæžã®äžã§èè ãã¯ãåæãã調æ»çµæã¯ãã€ãµã€ã¯ã«ã¹ããŒãªãŒãšåŒã°ããéå¶å©å£äœã«ãããã®ã§ãç¹ã«COVID-19ã¯ã¯ãã³å±éäžã«æçµåšæã«æ°ã¥ããå€åã«ã€ããŠçºèšãã女æ§ã®å£°ã確å®ã«èããããšèããŠãããšèª¬æããŠããã
MyCycleStoryã®åµèšè å Œç€Ÿé·ã§ããããã®ç ç©¶ã®å ±èè ã§ãããã£ãã¡ããŒã»ããããã¯ãMillions Against Mandatesãžã®æçš¿ã®äžã§ãCOVID-19ã¯ã¯ãã³å±éçŽåŸã®æçµåšæã®å€åã«é¢ããå人çãªèšŒèšãå ±æããŠãã2äžäººä»¥äžã®ã¡ã³ããŒãå«ãFacebookã°ã«ãŒããã2021幎ã«åé€ããããšæžããŠããã
ããã®ãããªåºæ¥äºã調æ»ããæ²é»ããããã女æ§ãã¡ã®å£°ãå±ããå¿ èŠæ§ã¯æããã§ããããšããããã¯æžããŠããã
ããã§ãã€ãµã€ã¯ã«ã¹ããŒãªãŒèª¿æ»ãäœæãããããšåœŒå¥³ã¯èšããããããã®èšŒèšãéããåå®ã«å¿ èŠãšãããŠããäŒè©±ã埩掻ãããããšãäžå¯æ¬ ã ã£ã"ã
91ã®è³ªåãããªããã®èª¿æ»ã¯ãCOVID-19ã¯ã¯ãã³å±éäžã®å¥³æ§ã®æçµäœéšãçè§£ããæ°å€åããããšãç®çãšããŠããã
6,000人以äžã®å¥³æ§ã2021幎5æ16æ¥ãã2021幎12æ31æ¥ã«ãããŠã¢ã³ã±ãŒãã«åçããã圌女ãã¡ã®å¹Žéœ¢ã¯18ã85æ³ã§ãå¹³å幎霢ã¯38æ³ã§ãã£ãã
ç ç©¶è ãã¯ãCOVID-19ã¯ã¯ãã³ãæ¥çš®ããªãã£ããšçãã3,390人ã®èª¿æ»åçè ã«çŠç¹ãçµã£ãŠåæãè¡ã£ãã
ãã®ç ç©¶ã®éçã¯ãèªå·±ç³åããŒã¿ã䜿çšããŠããããšã§ãããèªå·±å ±åãããŠãã人ãã¡ïŒãã®å Žåã¯ã¢ã³ã±ãŒãã«çãã女æ§ãã¡ïŒã¯ãåºæ¥äºã®èšæ¶ã«åããããå¯èœæ§ãããã
ããããæçµåšæã«é¢ããæ å ±åéã¯ãèªå·±ç³åã«ããããŒã¿ãæãæšæºçã§ãããšèè ãã¯ææããŠãããããã«ãŒæ°ã¯ãŸãããã®çš®ã®èª¿æ»ãå°éãšããããŒã±ãã£ã³ã°äŒç€Ÿã«ãã£ãŠè¡ããããã®èª¿æ»ã®å€ãã®è³ªåã¯ãæçµã®åé¡ãšã¯ã¯ãã³ã® ãè±èœ ãã®é¢ä¿ã«é¢ãããã®ã ãã§ã¯ãªãã£ããšææããã
ããã«ãŒæ°ã¯ããããã¯å°ãªããšãããããã¯æ³èµ·ãã€ã¢ã¹ãæå°åãã广ãããã ãã ããšè¿°ã¹ãã
ããŒã¿ãŒãºæ°ã¯ããã®ç ç©¶ã®ããäžã€ã®éçã¯ãå£ã³ãããœãŒã·ã£ã«ã¡ãã£ã¢ãã調æ»ãç¥ã£ã女æ§ã®äŸ¿å®çãµã³ãã«ã䜿çšããããšã§ãããšããã£ãã§ã³ããŒãçŽã«èªã£ãã
ããã³ãããã¯åãã¯ã¯ãã³æ¥çš®åã®æçµè¿œè·¡ã¢ããªãããã€ã¹ããã®ããŒã¿ãçšããéå£ããŒã¹ã®ç ç©¶ã¯ããããã©ã³ã¹ã®åããã¢ãããŒããæäŸã§ããã ãããããããã調æ»ãé åžãããéèŠãªææã«ã¯ãç ç©¶ããŒã ã¯ãã®ããŒã¿ãå ¥æã§ããªãã£ãã
ããŒã¿ãŒãºæ°ã¯ãNIHã¯2021幎8æãŸã§ã¯ã¯ãã³æ¥çš®è ã®ç°åžžã«é¢ããç ç©¶ãžã®å©æãéå§ããªãã£ããããç ç©¶ããŒã ãç ç©¶ãã¶ã€ã³ãæ¹åããããã®è³éãç±³åœåœç«è¡çç ç©¶æïŒNIHïŒããè¿ éã«ç¢ºä¿ã§ãããšã¯èãã«ãããšè¿°ã¹ãã
ããŒã¿ãŒãºæ°ã¯ããã®èª¿æ»çµæã¯ ãæ±ºããŠåçŸãããªããããããªããŠããŒã¯ãªç¬é ããåæ ããŠãããšè¿°ã¹ãã2021幎åé ãCOVID-19 mRNAã¯ã¯ãã³-ãå³å¯ãªè©ŠéšãçµãŠããªãã£ãã-ãçæéã§å€§èŠæš¡ãªéå£ã«å±éãããã
2021å¹Žã®æ©æ¥ä»¥æ¥ã倿°ã®å¥³æ§ãã¡ãæçµç°åžžãå ±åããŠããããšããŒã¿ãŒãºã¯èšã£ããããããã®å¥³æ§ãå©ããããšããèšåºå»ã«ãšã£ãŠæãåœæãããããã®ã¯ãæåã®éå£äºé²æ¥çš®ãã£ã³ããŒã³äžã«çç¶çºçŸãå ±åããã«ãããããããäºé²æ¥çš®ãåããªãã£ã女æ§ãã¡ã§ãã£ããã
ããã®ç¬ç«ããããã®ç ç©¶ã¯ãããšã調æ»èªå·±å ±åãã¶ã€ã³ãšããå¶éã®äžã§ãè³éæŽå©ããªããšããŠããç§åŠãå»åŠãèŠå¶æ©é¢ã®äžã§ããããã®å¥³æ§ãã¡ã«ãã匷ã声ãæäŸãããã®ã§ã "ãšããŒã¿ãŒãºã¯èªã£ãã